Corvus Pharmaceuticals Inc buy Cantor Fitzgerald
Start price
01.04.24
/
50%
€1.67
Target price
01.04.25
-
Performance (%)
71.74%
End price
02.04.25
€2.88
Summary
This prediction ended on 02.04.25 with a price of €2.88. The BUY prediction by Cantor_Fitzgerald for Corvus Pharmaceuticals Inc saw massive gains of 71.74%. Cantor_Fitzgerald has a follow-up prediction for Corvus Pharmaceuticals Inc where he still thinks Corvus Pharmaceuticals Inc is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Corvus Pharmaceuticals Inc | -5.200% | -5.200% | -6.447% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for CRVS provided by MarketBeat
In the thread Trading Corvus Pharmaceuticals Inc
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€7.16
11.12.25
11.12.25
-
11.12.26
11.12.26
-0.28%
11.12.25
11.12.25
Stopped prediction by Cantor_Fitzgerald for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.51
07.09.23
07.09.23
€3.74
07.09.24
07.09.24
146.36%
08.09.24
08.09.24